What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Bruno Fautrel mostly deals with Internal medicine, Rheumatoid arthritis, Surgery, Physical therapy and Epidemiology.
Internal medicine is closely attributed to Gastroenterology in his work.
His Rheumatoid arthritis study integrates concerns from other disciplines, such as Psoriasis, Magnetic resonance imaging and Arthritis.
His research investigates the connection with Surgery and areas like Connective tissue disease which intersect with concerns in Receiver operating characteristic and Area under the curve.
His Physical therapy study combines topics from a wide range of disciplines, such as Osteoarthritis, Intensive care medicine, Physical examination, Disease management and Cohort.
His Epidemiology research incorporates elements of Comorbidity, Incidence and Confidence interval.
His most cited work include:
- Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France (342 citations)
- Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. (323 citations)
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry (311 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Rheumatoid arthritis, Physical therapy, Cohort and Rheumatology.
His Internal medicine research integrates issues from Gastroenterology and Surgery.
Bruno Fautrel has included themes like Methotrexate and Intensive care medicine in his Rheumatoid arthritis study.
His research investigates the connection between Physical therapy and topics such as Alternative medicine that intersect with issues in Family medicine.
His studies in Cohort integrate themes in fields like Early arthritis, Logistic regression, Cohort study, Radiography and Prospective cohort study.
His study on Rheumatology is mostly dedicated to connecting different topics, such as Rheumatism.
He most often published in these fields:
- Internal medicine (51.38%)
- Rheumatoid arthritis (43.50%)
- Physical therapy (30.91%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (51.38%)
- Rheumatoid arthritis (43.50%)
- Cohort (19.69%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Cohort, Psoriatic arthritis and Rheumatology.
Bruno Fautrel performs integrative study on Internal medicine and In patient.
His Rheumatoid arthritis research includes elements of Methotrexate and Ankylosing spondylitis.
His biological study deals with issues like Observational study, which deal with fields such as Comparative effectiveness research.
His study in Rheumatology is interdisciplinary in nature, drawing from both Targeted therapy and Arthritis.
His Cohort study research focuses on subjects like Odds ratio, which are linked to Physical therapy.
Between 2018 and 2021, his most popular works were:
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial (102 citations)
- Update of French society for rheumatology recommendations for managing rheumatoid arthritis. (38 citations)
- Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology. (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Bruno Fautrel mainly focuses on Internal medicine, Rheumatoid arthritis, Cohort, Adalimumab and Methotrexate.
He undertakes multidisciplinary studies into Internal medicine and In patient in his work.
His Rheumatoid arthritis research includes themes of Clinical trial, Radiography, Post-hoc analysis, Ankylosing spondylitis and Autoimmune hepatitis.
Bruno Fautrel interconnects Infliximab and Incidence in the investigation of issues within Methotrexate.
His work carried out in the field of Rheumatology brings together such families of science as Targeted therapy and Arthritis.
His research in Osteoarthritis intersects with topics in Strictly standardized mean difference and Physical therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
